NCT00634426

Brief Summary

The aim of this trial is to evaluate the differences in pain relief, neurological function, quality of life and survival in patients with metastatic epidural spinal cord compression (MESCC) who are managed with a combination of surgery and radiotherapy versus radiotherapy alone. Further we shall evaluate cost-effectiveness of the two treatment approaches.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2008

Longer than P75 for all trials

Geographic Reach
2 countries

10 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2008

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

March 3, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 13, 2008

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

May 21, 2015

Status Verified

March 1, 2015

Enrollment Period

5 years

First QC Date

March 3, 2008

Last Update Submit

May 19, 2015

Conditions

Keywords

SpineNeoplasm metastasisTreatment, surgicalTreatment, nonoperativeQuality of life

Outcome Measures

Primary Outcomes (2)

  • Change in spine-associated pain intensity (BPI) measured by Brief Pain Inventory

    6 weeks / 3, 6, 9, 12, 18, 24 months

  • Neurological outcomes measured by American Spinal Injury Association (ASIA) Motor Scale structured clinical examination

    24 months

Secondary Outcomes (6)

  • Survival

    24 months

  • SF-36 v2

    24 month

  • EQ-5D

    24 months

  • Oswestry Disability Index (ODI)

    24 months

  • Caregiver Activity Survey

    24 months

  • +1 more secondary outcomes

Study Arms (3)

1

De novo surgical cohort

Procedure: Surgical excision of the metastatic process

2

Nonoperative treatment cohort

Radiation: Radiotherapy of the metastatic spine process

3

Secondary surgical treatment cohort

Procedure: Surgical excision of the metastatic process

Interventions

Surgical excision of the metastatic process

13

Standard of care radiotherapy for patients with metastatic epidural spinal cord compression.

2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who present for the treatment of new (cohorts 1 \& 3) or old (cohort 2) metastatic epidural spinal cord compression at the participating sites.

You may qualify if:

  • Single symptomatic metastatic epidural spinal compression at any level confirmed by MRI
  • Age 18 and more
  • Able and willing to give written informed consent to participate in the study
  • Able to read and write English on an elementary level

You may not qualify if:

  • Multiple symptomatic spinal metastases
  • Radiosensitive tumors
  • Radioresistant tumors
  • Primary cancer site in CNS or spine
  • Poor life expectancy (\< 3 months)
  • Patients with a tumor that has compressed only the cauda equina or spinal roots
  • Has a recent history of substance abuse
  • Is a prisoner
  • Currently involved in another study
  • has a disease or condition that would preclude accurate evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (10)

University of Kansas Medical Center

Kansas City, Kansas, 66160-0001, United States

Location

Johns Hopkins University

Baltimore, Maryland, 21287, United States

Location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Thomas Jefferson University and The Rothman Institute

Philadelphia, Pennsylvania, 19107-4216, United States

Location

University of Texas Hospital / MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

West Viginia University

Morgantown, West Virginia, 26506, United States

Location

University of British Columbia

Vancouver, British Columbia, V5Z 4E3, Canada

Location

Sunnybrook Health Sciences Center

Toronto, Ontario, M4N 3M5, Canada

Location

University of Toronto

Toronto, Ontario, M5T 2S8, Canada

Location

Related Publications (5)

  • Sciubba DM, Petteys RJ, Dekutoski MB, Fisher CG, Fehlings MG, Ondra SL, Rhines LD, Gokaslan ZL. Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine. 2010 Jul;13(1):94-108. doi: 10.3171/2010.3.SPINE09202.

    PMID: 20594024BACKGROUND
  • Furlan JC, Chan KK, Sandoval GA, Lam KC, Klinger CA, Patchell RA, Laporte A, Fehlings MG. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis. Neuro Oncol. 2012 May;14(5):631-40. doi: 10.1093/neuonc/nos062. Epub 2012 Apr 14.

    PMID: 22505658BACKGROUND
  • Fitzpatrick D, Grabarz D, Wang L, Bezjak A, Fehlings MG, Fosker C, Rampersaud R, Wong RK. How effective is a virtual consultation process in facilitating multidisciplinary decision-making for malignant epidural spinal cord compression? Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e167-72. doi: 10.1016/j.ijrobp.2012.03.057. Epub 2012 Jun 8.

  • Fisher CG, Schouten R, Versteeg AL, Boriani S, Varga PP, Rhines LD, Kawahara N, Fourney D, Weir L, Reynolds JJ, Sahgal A, Fehlings MG, Gokaslan ZL. Reliability of the Spinal Instability Neoplastic Score (SINS) among radiation oncologists: an assessment of instability secondary to spinal metastases. Radiat Oncol. 2014 Mar 4;9:69. doi: 10.1186/1748-717X-9-69.

  • Fisher CG, Versteeg AL, Schouten R, Boriani S, Varga PP, Rhines LD, Heran MK, Kawahara N, Fourney D, Reynolds JJ, Fehlings MG, Gokaslan ZL. Reliability of the spinal instability neoplastic scale among radiologists: an assessment of instability secondary to spinal metastases. AJR Am J Roentgenol. 2014 Oct;203(4):869-74. doi: 10.2214/AJR.13.12269.

MeSH Terms

Conditions

Neoplasm Metastasis

Condition Hierarchy (Ancestors)

Neoplastic ProcessesNeoplasmsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael Fehlings, MD FRCSC

    University of Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 3, 2008

First Posted

March 13, 2008

Study Start

March 1, 2008

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

May 21, 2015

Record last verified: 2015-03

Locations